Wird geladen...
How selecting best therapy for metastatic NTRK fusion-positive non-small cell lung cancer?
The tropomyosin receptor kinase (TRK) family of receptor tyrosine kinases has become a focus of clinical interest because the NTRK genes (NTRK1-3) encoding them have been identified as oncogenic fusion genes in a wide range of different tumor types, including lung cancer. These NTRK gene fusions usu...
Gespeichert in:
| Veröffentlicht in: | Transl Lung Cancer Res |
|---|---|
| 1. Verfasser: | |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
AME Publishing Company
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7815373/ https://ncbi.nlm.nih.gov/pubmed/33489816 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr-20-434 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|